tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Curaleaf Sets February 26 Date to Report Q4 and Full-Year 2025 Results

Story Highlights
  • Curaleaf will report its fourth-quarter and full-year 2025 results on February 26, 2026.
  • The earnings release and investor call highlight Curaleaf’s push for transparency as it expands in global cannabis markets.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Curaleaf Sets February 26 Date to Report Q4 and Full-Year 2025 Results

Claim 50% Off TipRanks Premium

An announcement from Curaleaf Holdings ( (TSE:CURA) ) is now available.

Curaleaf Holdings said it will release its fourth-quarter and full-year 2025 financial and operational results after markets close on February 26, 2026, followed by a management-hosted conference call and webcast at 5:00 p.m. ET the same day. The scheduled disclosure and investor call underscore the company’s efforts to maintain transparency with shareholders and analysts as it navigates a competitive global cannabis market and continues to build its presence in North American and European medical and adult-use segments.

The most recent analyst rating on (TSE:CURA) stock is a Hold with a C$3.50 price target. To see the full list of analyst forecasts on Curaleaf Holdings stock, see the TSE:CURA Stock Forecast page.

Spark’s Take on TSE:CURA Stock

According to Spark, TipRanks’ AI Analyst, TSE:CURA is a Neutral.

Curaleaf Holdings’ overall stock score is driven by a mix of financial challenges and technical strengths. The company’s financial performance is hindered by declining revenue and profitability, along with increased leverage. However, positive cash flow generation provides some stability. Technical analysis shows a positive trend, contributing to a higher score. Valuation remains a concern due to ongoing losses. The earnings call highlights international growth, but domestic challenges persist.

To see Spark’s full report on TSE:CURA stock, click here.

More about Curaleaf Holdings

Curaleaf Holdings, Inc. is a leading international cannabis company that provides consumer products across medical and adult-use markets. Through brands including Curaleaf, Select, Grassroots, Dark Heart, Anthem, JAMS and Find, the company offers a broad range of cannabis products and services, supported by a vertically integrated supply and distribution network. Curaleaf International is the largest vertically integrated cannabis operator in Europe, combining research, cultivation, extraction and production, and the company’s shares trade on the Toronto Stock Exchange and the OTCQX market.

Average Trading Volume: 1,029,298

Technical Sentiment Signal: Sell

Current Market Cap: C$2.71B

For an in-depth examination of CURA stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1